| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
catenin beta 1 | 0.303 | 0.885 | 1.00 |
|
disease | 0.400 | None | 0.995 | 9 | 0 | 1997 | 2020 | ||||||||
|
APC regulator of WNT signaling pathway | 0.373 | 0.962 | 1.00 |
|
disease | 0.500 | None | 0.948 | 7 | 0 | 1992 | 2019 | ||||||||
|
thymidylate synthetase | 0.425 | 0.846 | 0.72 |
|
disease | 0.400 | None | 0.979 | 6 | 0 | 1993 | 2019 | ||||||||
|
KRAS proto-oncogene, GTPase | 0.320 | 0.923 | 7.9E-04 |
|
disease | 0.500 | None | 0.981 | 6 | 0 | 1991 | 2019 | ||||||||
|
cyclin D1 | 0.344 | 0.923 | 0.89 |
|
disease | 0.400 | None | 0.958 | 4 | 0 | 2001 | 2018 | ||||||||
|
MYC proto-oncogene, bHLH transcription factor | 0.344 | 0.923 | 1.00 |
|
disease | 0.400 | None | 0.960 | 4 | 0 | 1984 | 2019 | ||||||||
|
prostaglandin-endoperoxide synthase 2 | 0.314 | 0.962 | 1.00 |
|
disease | 0.400 | None | 0.946 | 3 | 0 | 1996 | 2019 | ||||||||
|
tumor protein p53 | 0.236 | 0.962 | 0.53 |
|
disease | 0.500 | None | 0.966 | 3 | 0 | 1991 | 2020 | ||||||||
|
arachidonate 5-lipoxygenase | 0.447 | 0.885 | 1.2E-06 |
|
disease | 0.370 | None | 0.889 | 3 | 0 | 2004 | 2018 | ||||||||
|
BCL2 apoptosis regulator | 0.291 | 0.885 | 0.56 |
|
disease | 0.600 | None | 1.000 | 3 | 0 | 1997 | 2019 | ||||||||
|
interleukin 1 beta | 0.276 | 0.962 | 0.13 |
|
disease | 0.400 | None | 1.000 | 3 | 0 | 1993 | 2020 | ||||||||
|
solute carrier organic anion transporter family member 1B3 | 0.592 | 0.769 | 5.3E-24 |
|
disease | 0.310 | None | 1.000 | 2 | 0 | 2008 | 2014 | ||||||||
|
3-hydroxy-3-methylglutaryl-CoA synthase 2 | 0.666 | 0.577 | 4.3E-14 |
|
disease | 0.310 | None | 1.000 | 2 | 0 | 2004 | 2017 | ||||||||
|
baculoviral IAP repeat containing 5 | 0.495 | 0.731 | 5.6E-02 |
|
disease | 0.300 | None | 1.000 | 2 | 0 | 2005 | 2009 | ||||||||
|
Jun proto-oncogene, AP-1 transcription factor subunit | 0.442 | 0.885 | 6.0E-02 |
|
disease | 0.350 | None | 1.000 | 2 | 0 | 2003 | 2019 | ||||||||
|
epidermal growth factor receptor | 0.295 | 0.885 | 0.37 |
|
disease | 0.400 | None | 0.979 | 2 | 0 | 1989 | 2019 | ||||||||
|
intercellular adhesion molecule 1 | 0.364 | 0.962 | 3.5E-02 |
|
disease | 0.350 | None | 0.833 | 2 | 0 | 1993 | 2015 | ||||||||
|
tumor necrosis factor | 0.231 | 0.962 | 0.80 |
|
disease | 0.400 | None | 1.000 | 2 | 0 | 1994 | 2020 | ||||||||
|
folate receptor alpha | 0.522 | 0.885 | 0.13 |
|
disease | 0.310 | None | 1.000 | 2 | 0 | 2005 | 2018 | ||||||||
|
XIAP associated factor 1 | 0.587 | 0.769 | 6.8E-12 |
|
disease | 0.350 | None | 1.000 | 2 | 0 | 2005 | 2010 | ||||||||
|
proliferating cell nuclear antigen | 0.382 | 0.846 | 0.98 |
|
disease | 0.350 | None | 1.000 | 2 | 0 | 1998 | 2014 | ||||||||
|
nitric oxide synthase 2 | 0.364 | 0.923 | 4.0E-15 |
|
disease | 0.340 | None | 1.000 | 2 | 0 | 2005 | 2012 | ||||||||
|
nuclear factor kappa B subunit 1 | 0.396 | 0.923 | 1.00 |
|
disease | 0.330 | None | 1.000 | 2 | 0 | 2009 | 2013 | ||||||||
|
solute carrier family 5 member 8 | 0.615 | 0.577 | 5.0E-16 |
|
disease | 0.380 | None | 1.000 | 2 | 0 | 2003 | 2017 | ||||||||
|
PRR5-ARHGAP8 readthrough | 0.821 | 0.154 | 2.1E-28 |
|
disease | 0.300 | None | 1.000 | 1 | 0 | 2014 | 2014 |